دورية أكاديمية
أعرض في EDS

Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension

التفاصيل البيبلوغرافية
العنوان: Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension
المؤلفون: FOGARI, ROBERTO, DEROSA, GIUSEPPE, Zoppi A, Salvadeo SAT, Mugellini A, Lazzari P, Santoro T
المساهمون: Fogari, Roberto, Zoppi, A, Salvadeo, Sat, Mugellini, A, Lazzari, P, Santoro, T, Derosa, Giuseppe
سنة النشر: 2011
المجموعة: IRIS UNIPV (Università degli studi di Pavia)
مصطلحات موضوعية: Adolescent, Adult, Aged, Angiotensin II Type 1 Receptor Blocker, pharmacology/therapeutic use, Angiotensin II, physiology, Angiotensin-Converting Enzyme Inhibitor, Benzimidazole, Blood Pressure, drug effects/physiology, Endothelium, Vascular, physiopathology, Female, Fibrinolysi, Humans, Hypertension, blood/drug therapy/physiopathology, Imidazolidine, Insulin Resistance, Male, Middle Aged, Plasminogen Activator Inhibitor 1, blood, Prospective Studies, Signal Transduction, Single-Blind Method, Tetrazole, Tissue Plasminogen Activator
الوصف: The aim of this study was to evaluate the effects of imidapril and candesartan on fibrinolysis and insulin sensitivity in normoweight hypertensive patients. After a 2-week wash-out period, 61 patients with mild-to-moderate hypertension were randomized to imidapril or candesartan for 12 weeks. Blood pressure (BP), plasma tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) antigen activities were evaluated at baseline and during treatment. The patients underwent a euglycemic-hyperinsulinemic clamp (insulin sensitivity was evaluated as glucose infusion rate during the last 30 min) and a desmopressin test (with desmopressin infusion in the brachial artery) to evaluate endothelial ability to release t-PA. Imidapril and candesartan induced similar systolic/diastolic BP reductions (-16/12.6 and -16.1/12.2 mm Hg, respectively, P<0.001 vs. baseline). Imidapril increased glucose infusion rate (+1.1 mg min(-1) per kg, P<0.02), whereas candesartan did not change it. Both drugs decreased PAI-1 antigen activity after 4 weeks of treatment; subsequently, only the decreasing effect of imidapril was sustained throughout the 12 weeks, whereas candesartan increased PAI-1 activity at week 12 (P<0.05 vs. baseline, P<0.01 vs. imidapril). Activity of t-PA decreased with candesartan (from 0.48±0.16 to 0.43±0.14 IU ml(-1), P<0.05) but not with imidapril. Activity of t-PA in response to desmopressin was increased more by imidapril (+4.45 IU ml(-1)) than by candesartan (+2.73 IU ml(-1), P<0.01 vs. imidapril). These results indicate that in normoweight hypertensive patients, despite similar BP reduction, imidapril but not candesartan improved the fibrinolytic balance, suggesting that mechanisms other than Ang II inhibition, possibly including bradykinin-mediated effects on insulin sensitivity and endothelial function, may be responsible for these different effects.
نوع الوثيقة: article in journal/newspaper
وصف الملف: ELETTRONICO
اللغة: English
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/21179101; info:eu-repo/semantics/altIdentifier/wos/000289194100019; volume:34; firstpage:509; lastpage:515; numberofpages:6; journal:HYPERTENSION RESEARCH; http://hdl.handle.net/11571/378827Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-79953680485; http://dx.doi.org/10.1038/hr.2010.260Test
DOI: 10.1038/hr.2010.260
الإتاحة: https://doi.org/10.1038/hr.2010.260Test
http://hdl.handle.net/11571/378827Test
رقم الانضمام: edsbas.22E9A30D
قاعدة البيانات: BASE
ResultId 1
Header edsbas
BASE
edsbas.22E9A30D
773
3
Academic Journal
academicJournal
772.654235839844
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.22E9A30D&custid=s6537998&authtype=sso
FullText Array ( [Availability] => 0 )
Array ( [0] => Array ( [Url] => https://doi.org/10.1038/hr.2010.260# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) )
Items Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension )
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => &lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22FOGARI%2C+ROBERTO%22&quot;&gt;FOGARI, ROBERTO&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22DEROSA%2C+GIUSEPPE%22&quot;&gt;DEROSA, GIUSEPPE&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Zoppi+A%22&quot;&gt;Zoppi A&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Salvadeo+SAT%22&quot;&gt;Salvadeo SAT&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Mugellini+A%22&quot;&gt;Mugellini A&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Lazzari+P%22&quot;&gt;Lazzari P&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;AR&quot; term=&quot;%22Santoro+T%22&quot;&gt;Santoro T&lt;/searchLink&gt; )
Array ( [Name] => Author [Label] => Contributors [Group] => Au [Data] => Fogari, Roberto&lt;br /&gt;Zoppi, A&lt;br /&gt;Salvadeo, Sat&lt;br /&gt;Mugellini, A&lt;br /&gt;Lazzari, P&lt;br /&gt;Santoro, T&lt;br /&gt;Derosa, Giuseppe )
Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2011 )
Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => IRIS UNIPV (Universit&#224; degli studi di Pavia) )
Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => &lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Adolescent%22&quot;&gt;Adolescent&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Adult%22&quot;&gt;Adult&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Aged%22&quot;&gt;Aged&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Angiotensin+II+Type+1+Receptor+Blocker%22&quot;&gt;Angiotensin II Type 1 Receptor Blocker&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22pharmacology%2Ftherapeutic+use%22&quot;&gt;pharmacology/therapeutic use&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Angiotensin+II%22&quot;&gt;Angiotensin II&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22physiology%22&quot;&gt;physiology&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Angiotensin-Converting+Enzyme+Inhibitor%22&quot;&gt;Angiotensin-Converting Enzyme Inhibitor&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Benzimidazole%22&quot;&gt;Benzimidazole&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Blood+Pressure%22&quot;&gt;Blood Pressure&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22drug+effects%2Fphysiology%22&quot;&gt;drug effects/physiology&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Endothelium%22&quot;&gt;Endothelium&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Vascular%22&quot;&gt;Vascular&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22physiopathology%22&quot;&gt;physiopathology&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Female%22&quot;&gt;Female&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Fibrinolysi%22&quot;&gt;Fibrinolysi&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Humans%22&quot;&gt;Humans&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Hypertension%22&quot;&gt;Hypertension&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22blood%2Fdrug+therapy%2Fphysiopathology%22&quot;&gt;blood/drug therapy/physiopathology&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Imidazolidine%22&quot;&gt;Imidazolidine&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Insulin+Resistance%22&quot;&gt;Insulin Resistance&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Male%22&quot;&gt;Male&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Middle+Aged%22&quot;&gt;Middle Aged&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Plasminogen+Activator+Inhibitor+1%22&quot;&gt;Plasminogen Activator Inhibitor 1&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22blood%22&quot;&gt;blood&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Prospective+Studies%22&quot;&gt;Prospective Studies&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Signal+Transduction%22&quot;&gt;Signal Transduction&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Single-Blind+Method%22&quot;&gt;Single-Blind Method&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Tetrazole%22&quot;&gt;Tetrazole&lt;/searchLink&gt;&lt;br /&gt;&lt;searchLink fieldCode=&quot;DE&quot; term=&quot;%22Tissue+Plasminogen+Activator%22&quot;&gt;Tissue Plasminogen Activator&lt;/searchLink&gt; )
Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => The aim of this study was to evaluate the effects of imidapril and candesartan on fibrinolysis and insulin sensitivity in normoweight hypertensive patients. After a 2-week wash-out period, 61 patients with mild-to-moderate hypertension were randomized to imidapril or candesartan for 12 weeks. Blood pressure (BP), plasma tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) antigen activities were evaluated at baseline and during treatment. The patients underwent a euglycemic-hyperinsulinemic clamp (insulin sensitivity was evaluated as glucose infusion rate during the last 30 min) and a desmopressin test (with desmopressin infusion in the brachial artery) to evaluate endothelial ability to release t-PA. Imidapril and candesartan induced similar systolic/diastolic BP reductions (-16/12.6 and -16.1/12.2 mm Hg, respectively, P&lt;0.001 vs. baseline). Imidapril increased glucose infusion rate (+1.1 mg min(-1) per kg, P&lt;0.02), whereas candesartan did not change it. Both drugs decreased PAI-1 antigen activity after 4 weeks of treatment; subsequently, only the decreasing effect of imidapril was sustained throughout the 12 weeks, whereas candesartan increased PAI-1 activity at week 12 (P&lt;0.05 vs. baseline, P&lt;0.01 vs. imidapril). Activity of t-PA decreased with candesartan (from 0.48&#177;0.16 to 0.43&#177;0.14 IU ml(-1), P&lt;0.05) but not with imidapril. Activity of t-PA in response to desmopressin was increased more by imidapril (+4.45 IU ml(-1)) than by candesartan (+2.73 IU ml(-1), P&lt;0.01 vs. imidapril). These results indicate that in normoweight hypertensive patients, despite similar BP reduction, imidapril but not candesartan improved the fibrinolytic balance, suggesting that mechanisms other than Ang II inhibition, possibly including bradykinin-mediated effects on insulin sensitivity and endothelial function, may be responsible for these different effects. )
Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => article in journal/newspaper )
Array ( [Name] => Format [Label] => File Description [Group] => SrcInfo [Data] => ELETTRONICO )
Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English )
Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => info:eu-repo/semantics/altIdentifier/pmid/21179101; info:eu-repo/semantics/altIdentifier/wos/000289194100019; volume:34; firstpage:509; lastpage:515; numberofpages:6; journal:HYPERTENSION RESEARCH; http://hdl.handle.net/11571/378827; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-79953680485; http://dx.doi.org/10.1038/hr.2010.260 )
Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.1038/hr.2010.260 )
Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://doi.org/10.1038/hr.2010.260&lt;br /&gt;http://hdl.handle.net/11571/378827 )
Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.22E9A30D )
RecordInfo Array ( [BibEntity] => Array ( [Identifiers] => Array ( [0] => Array ( [Type] => doi [Value] => 10.1038/hr.2010.260 ) ) [Languages] => Array ( [0] => Array ( [Text] => English ) ) [Subjects] => Array ( [0] => Array ( [SubjectFull] => Adolescent [Type] => general ) [1] => Array ( [SubjectFull] => Adult [Type] => general ) [2] => Array ( [SubjectFull] => Aged [Type] => general ) [3] => Array ( [SubjectFull] => Angiotensin II Type 1 Receptor Blocker [Type] => general ) [4] => Array ( [SubjectFull] => pharmacology/therapeutic use [Type] => general ) [5] => Array ( [SubjectFull] => Angiotensin II [Type] => general ) [6] => Array ( [SubjectFull] => physiology [Type] => general ) [7] => Array ( [SubjectFull] => Angiotensin-Converting Enzyme Inhibitor [Type] => general ) [8] => Array ( [SubjectFull] => Benzimidazole [Type] => general ) [9] => Array ( [SubjectFull] => Blood Pressure [Type] => general ) [10] => Array ( [SubjectFull] => drug effects/physiology [Type] => general ) [11] => Array ( [SubjectFull] => Endothelium [Type] => general ) [12] => Array ( [SubjectFull] => Vascular [Type] => general ) [13] => Array ( [SubjectFull] => physiopathology [Type] => general ) [14] => Array ( [SubjectFull] => Female [Type] => general ) [15] => Array ( [SubjectFull] => Fibrinolysi [Type] => general ) [16] => Array ( [SubjectFull] => Humans [Type] => general ) [17] => Array ( [SubjectFull] => Hypertension [Type] => general ) [18] => Array ( [SubjectFull] => blood/drug therapy/physiopathology [Type] => general ) [19] => Array ( [SubjectFull] => Imidazolidine [Type] => general ) [20] => Array ( [SubjectFull] => Insulin Resistance [Type] => general ) [21] => Array ( [SubjectFull] => Male [Type] => general ) [22] => Array ( [SubjectFull] => Middle Aged [Type] => general ) [23] => Array ( [SubjectFull] => Plasminogen Activator Inhibitor 1 [Type] => general ) [24] => Array ( [SubjectFull] => blood [Type] => general ) [25] => Array ( [SubjectFull] => Prospective Studies [Type] => general ) [26] => Array ( [SubjectFull] => Signal Transduction [Type] => general ) [27] => Array ( [SubjectFull] => Single-Blind Method [Type] => general ) [28] => Array ( [SubjectFull] => Tetrazole [Type] => general ) [29] => Array ( [SubjectFull] => Tissue Plasminogen Activator [Type] => general ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => FOGARI, ROBERTO ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => DEROSA, GIUSEPPE ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Zoppi A ) ) ) [3] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Salvadeo SAT ) ) ) [4] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Mugellini A ) ) ) [5] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Lazzari P ) ) ) [6] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Santoro T ) ) ) [7] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Fogari, Roberto ) ) ) [8] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Zoppi, A ) ) ) [9] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Salvadeo, Sat ) ) ) [10] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Mugellini, A ) ) ) [11] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Lazzari, P ) ) ) [12] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Santoro, T ) ) ) [13] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Derosa, Giuseppe ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 01 [M] => 01 [Type] => published [Y] => 2011 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-locals [Value] => edsbas ) ) ) ) ) ) )
IllustrationInfo